BiotechTube

Istradefylline + Phentermine 45 mg

Phase 1Completed
0 watching 0 views this week💤 Quiet
33
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Drug Abuse

Conditions

Drug Abuse

Trial Timeline

Jan 1, 2016 → Jul 1, 2016

NCT ID
NCT02609477

About Istradefylline + Phentermine 45 mg

Istradefylline + Phentermine 45 mg is a phase 1 stage product being developed by Kyowa Kirin for Drug Abuse. The current trial status is completed. This product is registered under clinical trial identifier NCT02609477. Target conditions include Drug Abuse.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT02609477Phase 1Completed

Competing Products

20 competing products in Drug Abuse

See all competitors
ProductCompanyStageHype Score
ORIN1001Fosun PharmaPhase 1/2
40
GP404141 + NplateGEROPHARMPhase 3
69
Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg)YuhanPhase 1
33
Tolbutamide + Midazolam + PexidartinibDaiichi SankyoPhase 1
33
DS-8500a + RosuvastatinDaiichi SankyoPhase 1
33
DS-1040b + ClopidogrelDaiichi SankyoPhase 1
33
EC905 + verapamilAstellas PharmaPhase 1
33
rosuvastatin + fidaxomicinAstellas PharmaPhase 1
33
enzalutamide + rifampinAstellas PharmaPhase 1
33
ASP3652 + Gemfibrozil + RepaglinideAstellas PharmaPhase 1
33
CefiderocolShionogiApproved
85
Placebo + Active Comparator #1 + Active Comparator #2 + Active Comparator #3 + Lorcaserin Dose #1 + Lorcaserin Dose #2 + Lorcaserin Dose #3EisaiPhase 1
33
Lasmiditan + Alprazolam + PlaceboEli LillyPhase 1
33
Nasal Glucagon (NG) + Glucagon IMEli LillyPhase 3
77
napabucasin + cytochrome P450 (CYP450) probe drugs or BCRP transporter substrateSumitomo PharmaPhase 1
33
Norgestimate; Ethinyl Estradiol; Folic acidJohnson & JohnsonPhase 1
33
Norgestimate; Ethinyl Estradiol; Folic acidJohnson & JohnsonPhase 1
33
Loperamide / Red Grapefruit Juice + Loperamide/ White Grapefruit Juice + Loperamide / Pink Grapefruit JuiceJohnson & JohnsonPhase 1
33
HR17031 injection + insulin glargineJiangsu Hengrui MedicinePhase 3
77
Pyrotinib Maleate + EfavirenzJiangsu Hengrui MedicinePhase 1
33

Other Products from Kyowa Kirin

KRN23Approved
85
Istradefylline PillApproved
85
MogamulizumabApproved
85
KRN23Approved
85
KHK4827-Active + KHK4827-PlaceboApproved
85